paralysis
Most Read
Changing the definition of ‘fully vaccinated’ is more than just semantics, experts argue
Biogen’s reckoning: How the Aduhelm debacle pushed a troubled company and its fractured leadership to the brink
A first, small study suggests Omicron is a larger threat to Covid-19 immunity than other variants
Martin Shkreli’s former company pays $40 million for blocking competition for a life-saving drug
Centene agrees to pay $28 million to resolve another state probe into its pharmacy benefits business
Pear makes its stock market debut & telehealth players lock arms
